These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20129840)

  • 1. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer.
    Sakamoto J; Fujiya M; Okamoto K; Nata T; Inaba Y; Moriichi K; Tanabe H; Mizukami Y; Watari J; Ashida T; Kohgo Y
    Cancer Epidemiol; 2010 Apr; 34(2):194-9. PubMed ID: 20129840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
    Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
    Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer.
    Nakayama G; Kodera Y; Ohashi N; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2011 May; 31(5):1643-6. PubMed ID: 21617221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
    Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
    Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer.
    Ikoma H; Ichikawa D; Daito I; Nobuyuki T; Koike H; Okamoto K; Ochiai T; Ueda Y; Yamagishi H; Otsuji E
    Hepatogastroenterology; 2007; 54(75):946-50. PubMed ID: 17591100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
    Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
    Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma.
    Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
    Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
    Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
    Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
    Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.
    Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y
    Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
    Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
    Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
    Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
    Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
    Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating methylated DNA.
    Herman JG
    Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.